Glenmark Pharmaceutical Inc recalls ranitidine tablets in US
The tablets are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the United States Food and Drug Administration (USFDA), as per the company's announcement posted on the website of the US health regulator. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 21, 2019 Category: Pharmaceuticals Source Type: news
Glenmark Pharmaceuticals Inc., USA Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
Glenmark Pharmaceutical Inc., USA ( “Glenmark”) today announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 18, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Class 2 Medicines Recall: Medley Pharma Limited, Ranitidine 150mg Tablets BP, PL 43870/0026, Ranitidine 300mg Tablets BP, PL 43870/0027
Medley Pharma Limited is... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 16, 2019 Category: Drugs & Pharmacology Source Type: news
Class 2 Medicines recall: Ranitidine 150mg Film-Coated Tablets, PL 20075/0063, Ranitidine 300mg Film-Coated Tablets, PL 20075/0064
Accord Healthcare are recalling all unexpired stock of the Ranitidine 150mg Film-Coated Tablets and Ranitidine 300mg Film-Coated Tablets products from pharmacies, retail stores and wholesalers as a pr (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 5, 2019 Category: Drugs & Pharmacology Source Type: news
Class 2 Medicines recall: Ranitidine 150mg Film-Coated Tablets, PL 20075/0063, Ranitidine 300mg Film-Coated Tablets, PL 20075/0064
Accord Healthcare are recalling all unexpired stock of the above products from pharmacies, retail stores and wholesalers as a precautionary measure, due to possible contamination with an impurityN-nit (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 5, 2019 Category: Drugs & Pharmacology Source Type: news
Class 2 Medicines recall: Ranitidine 150mg Film-Coated Tablets, PL 20075/0063, Ranitidine 300mg Film-Coated Tablets, PL 20075/0064
Accord Healthcare are recalling all unexpired stock of the Ranitidine 150mg Film-Coated Tablets and Ranitidine 300mg Film-Coated Tablets products from pharmacies, retail stores and wholesalers as a pr (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 5, 2019 Category: Drugs & Pharmacology Source Type: news
